Yarrow Bioscience (YARW) Market Capitalization (2018 - 2026)

Yarrow Bioscience (YARW) has reported Market Capitalization for 9 consecutive years, with $27.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 60.42% year-over-year to $27.9 million; the trailing twelve-month figure through Jun 2026 stood at $27.9 million (down 60.42% YoY), and the FY2025 full-year result was $24.8 million, down 82.61% from the prior year.
• Market Capitalization advanced to $27.9 million in Q2 2026 per YARW's latest filing, from $25.6 million in the prior quarter.
• Across five years, Market Capitalization topped out at $677.5 million in Q1 2022 and bottomed at $8.7 million in Q4 2022.
• Historically, Market Capitalization has averaged $120.0 million across 5 years, with a median of $67.4 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Market Capitalization plunged 99.11% in 2022, then soared 1197.43% in 2024.
• Over 5 years, Market Capitalization stood at $8.7 million in 2022, then soared by 174.49% to $23.9 million in 2023, then jumped by 496.06% to $142.7 million in 2024, then sank by 82.61% to $24.8 million in 2025, then grew by 12.59% to $27.9 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $27.9 million, $25.6 million, and $24.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.